1. FDA. Coronavirus (COVID-19) Update: FDA Authorizes Moderna, Pfizer-BioNTech Bivalent COVID-19 Vaccines for Use as a Booster Dose. Published 2022. Accessed October 2, 2022. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-moderna-pfizer-biontech-bivalent-covid-19-vaccines-use
2. EMA. Adapted vaccine targeting BA.4 and BA.5 Omicron variants and original SARS-CoV-2 recommended for approval. Published 2022. Accessed October 2, 2022. https://www.ema.europa.eu/en/news/adapted-vaccine-targeting-ba4-ba5-omicron-variants-original-sars-cov-2-recommended-approval
3. Barbier AJ, Yujie Jiang A, Zhang P, Wooster R, Anderson DG. The clinical progress of mRNA vaccines and immunotherapies. doi:10.1038/s41587-022-01294-2
4. mRNA pioneers refocus on therapeutics;Garber;Nat Rev Drug Discov,2022
5. Clinical advances and ongoing trials on mRNA vaccines for cancer treatment;Lorentzen;Lancet Oncol,2022